Molecular Partners’ Post

We are very excited to be representing various clients at the Biotechnology Innovation Organization International Convention in a few weeks. Renaud will be in San Diego and is always open to making new connections and sharing about the innovative biotechnologies and biopharmaceuticals our clients are working on bringing to the market. We are attending to support various clients in the area of biopharmaceuticals, drug delivery, advanced therapies, and biomanufacturing in their search for investment and strategic partners, but are open to any meeting requests. The BIO One-on-One Partnering System is now open for booking meetings with us. Attending BIO 2024? Click below to send Omnium Global a meeting request in the BIO partnering system! #BIO2024 https://lnkd.in/gZ6rTSx3 Looking forward to exploring potential collaborations! About Bio Events International Convention: The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with over 20,000 industry leaders from across the globe. Whether you work at a public pharmaceutical company, biotech startup, academia, non-profits, and government or are a researcher, business development professional or investor, BIO is where you'll make valuable connections and build relationships. At BIO 2024, where issues & insights converge, you can access more than 100 sessions across 18 focus areas with discussions from leading biotechnology companies, investors, service providers, government officials, regulators, and patient advocates committed to ground-breaking therapies and innovation. June 3-6, 2024 - San Diego Convention Center, California #biotechinnovation #biotech #networking #Collaboration #partners #vaccineinnovation #biotechnology #startups#biomanufacturing #biopharma #advancedtherapies #BIO #innovation 

According to Reuters, the increased approval of novel drugs may lead to a surge in biotech investments and growth. Our recent blog discusses the potential challenges of finding biotech talent and strategies to ensure your organization hires the employees it needs to fuel growth this year. Read it here: https://hubs.ly/Q02rGySz0

The radiopharmaceutical market is exptected to grow significantly fueling increased investment and #biopharma M&A activity. #radioligandtherapy #RLT #radiopharmaceuticals #nuclearmedicine #pharma #biotech #advancedtherapies

🚀 Bio-Sourcing Secures €12.5M in EIC Accelerator Funding, Strengthening Its Drive to Lower Biosimilar Production Costs 🚀 Bio-Sourcing has been awarded €12.5M from the European Innovation Council (#EIC) Accelerator, consisting of a €2.5M grant and €10M in equity. This investment validates the potential of the BioMilk™ platform to revolutionize biomanufacturing and improve accessibility to critical biotherapeutics. #BioMilk™ enables large-scale production of biotherapeutics using goat milk, offering a fivefold reduction in costs and carbon emissions compared to traditional methods. The funding will fast-track clinical trials for the adalimumab (Humira) biosimilar, scheduled for 2027, making life-saving treatments more affordable and accessible. The €10M equity will support facility expansion, including a goat facility scale-up and the construction of an industrial milk processing plant. Impact: This achievement enhances Bio-Sourcing's efforts to reduce the cost of biotherapeutics and strengthens Europe’s sovereignty in biopharmaceutical manufacturing, contributing to global healthcare resilience. "The support from the EIC Accelerator underscores the importance of the BioMilk™ platform in addressing global healthcare challenges," said Dr. Bertrand Mérot,Founder & CEO Bio-Sourcing . Bernard Linsmeau BioWin #Biotech #Innovation #EICAccelerator #Biosimilars #BioSourcing #Healthcare #Biomanufacturing #Belgium Wallonia Export & Investment Agency Michel Kempeneers Guillaume de Bassompierre Emmanuelle Timmermans Mehdy Oozeer Evgeniya Ulkina

🌐 How do you transition from local R&D to global commercial success in BioPharma?   📘 Find out in our newly released whitepaper, packed with expert insights and actionable strategies – a must-read for #biotech firms looking to scale globally.   🔬 The whitepaper includes topics such as: - Integrating commercial thinking into R&D from the start - Pitfalls of emerging innovator companies - Launching a first product while building the organization - Setting realistic expectations for biotech fundraising and launch - 7 “make or break” factors for emerging biopharma companies   💡 Whether you are preparing for your first product launch or looking to refine your approach to global markets, this guide helps you navigate the complexities of the #biopharma industry.   👇 Swipe through the whitepaper below or download the full version here: https://lnkd.in/d7KB9K73.   🔍 If you want to find out more about the vibrant biotech ecosystem in the Greater Zurich Area, please click here: https://lnkd.in/dA6YX8yD.   Nicola Heffron, Alexion Pharmaceuticals, Inc.; Joe Magliocco, Blue Matter; Paul Pospisil, Korn Ferry; Thomas W. Fuchs, MSc, MBA, Economic Promotion Canton of Zug #innovation #pharma #research #development #commercialization

Early 2024 saw an uptick in dealmaking activity in the bio/pharma industry, and this momentum is likely to continue. What is attractive? Acquiring de-risked, quality assets that can uplift the innovation deficit and replenish revenue streams. TCG Labs Soleil is poised to deliver. Our model offers pharma and biotech with vetted assets ready for efficient adoption and development.  Learn more: https://lnkd.in/gCV9YAp5

Dive into BioSpectrum Asia's Company Spotlight and explore the stories of trailblazing companies driving breakthroughs in biotechnology, pharma, and life sciences across Asia. Check out the last six months' performance of top companies and get insights into their innovations, strategies, and impact on the global stage. #CompanySpotlight : https://lnkd.in/dUysJaQ2 Stay ahead with the latest trends and success stories from the region's biotech leaders! #Biotech #Innovation #LifeSciences #BioSpectrumAsia

Starting at 1.10 pm: Pitches by startups in clusters Life Sciences / Biotech and Pharma. Watch the #DeVigier Selection Day Top 50 live at http://devigier.ch #lifesciences #biotechnology #pharma

There’s an air of cautious optimism about 2024, after a difficult few years following the end of the pandemic when investment in pharma and biotech research dropped substantially... READ ARTICLE #ANPharmaUpdate #Pharmanews #pharmamarketing #pharmamarketingnews

🌍 The future of biotechnologies is bright, and the global landscape is evolving rapidly! You might wonder, where is the ideal global destination to benefit from future success and growth? The global biotech market, valued at $1.38 trillion in 2023, is projected to soar to $4.25 trillion by 2033 according to Precedence Research. ‘The State of the Biopharmaceutical Industry 2024’, by GlobalData Healthcare, also reports that 40% of healthcare professionals are optimistic about biotech funding making a strong comeback in 2024.🌱 👉 From cutting-edge startups to established industry leaders, the Basel Area is where the future of biotech is being shaped. While the United States remains the dominant force in the biotech industry, Switzerland continues to excel in R&D intensity, and the Basel Area in particular, plays a pivotal role in the global biotech landscape. The British magazine, Drug Discovery World, highlights Switzerland as one of the world’s most important biotech innovation centers, with 20% of European biotech companies headquartered in the country. The article describes the Basel Area as "the most developed biotech center in Switzerland," driven by the presence of biopharma giants like #Lonza, #Novartis, and #Roche, and a dense network of biotech companies leading in groundbreaking R&D, contributing to the global growth of biotechnology. Read more here > https://lnkd.in/dJCGvPMR ---- Follow us on #discoverthebaselarea Basel Area Business & Innovation #Biotech #Switzerland #Innovation #Pharmaceuticals #BaselArea #ResearchAndDevelopment #LifeSciences #FutureOfBiotech Invest in Switzerland | Business Location Switzerland | Switzerland Global Enterprise